Keyphrases
Clinical Practice
100%
Data Registry
100%
Electronic Information
100%
Fulvestrant
100%
Practice Use
100%
Advanced Breast Cancer
42%
Disease Progression
28%
Aromatase Inhibitors
28%
Endocrine Therapy
28%
Endocrine Treatment
28%
Median Time
28%
Clinical Trials
14%
Clinical Activity
14%
Postmenopausal Women
14%
United States
14%
Clinical Benefit
14%
Advanced Disease
14%
Tumor Resistance
14%
Early Breast Cancer
14%
Postmenopausal Patients
14%
Mode of Action
14%
Cytotoxic Chemotherapy
14%
Resistance to Endocrine Therapy
14%
Objective Response
14%
Surveillance Studies
14%
Time to Progression
14%
Inhibitor Treatment
14%
Duration of Response
14%
Complete Response
14%
Postmarketing
14%
Further Treatment
14%
Time Response
14%
Hormone Receptor-positive Advanced Breast Cancer
14%
Internet Surveillance
14%
Nursing and Health Professions
Clinical Practice
100%
Fulvestrant
100%
Hormonal Therapy
71%
Breast Cancer
71%
Disease Exacerbation
28%
Aromatase Inhibitor
28%
Treatment Response Time
14%
Tumor Resistance
14%
Hormone Receptor
14%
Diseases
14%
Pharmacology, Toxicology and Pharmaceutical Science
Fulvestrant
100%
Breast Cancer
71%
Endocrine Therapy
42%
Disease Exacerbation
28%
Aromatase Inhibitor
28%
Cytotoxic Chemotherapy
14%
Clinical Trial
14%
Tumor Resistance
14%
Hormone Receptor
14%
Diseases
14%